within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B03A_IronPreparations.B03AA03_FerrousGluconate;

model FerrousGluconate
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.1,
    Cl = 2.4166666666666665e-07,
    adminDuration = 600,
    adminMass = 325 / 1000000,
    adminCount = 1,
    Vd = 0.008,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0008333333333333334,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>FerrousGluconate</td></tr><tr><td>ATC code:</td><td>B03AA03</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>325</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>8</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.87</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Ferrous gluconate is an iron salt used to treat or prevent iron deficiency anemia. It is an orally administered iron supplement commonly used for patients with low iron levels. It is an approved drug by regulatory agencies and is in clinical use today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals after oral administration. No direct human publication reporting full compartmental PK parameters found; values estimated from related iron oral supplements and general iron pharmacokinetic knowledge.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.B.B03AA03 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end FerrousGluconate;
